Abstract:Our recent studies document that RAS is activated by and critical for FSH-induced signaling events and the regulation of target genes in cultured granulosa cells (Wayne et al, 2007). Subsequent studies document that KRAS is highly expressed in granulosa cells and is activated by LH/hCG, providing additional evidence that FSH- and LH- mediated events in granulosa cells are regulated, in part, by KRAS. However, the functions of KRAS in granulosa cells during follicular development in vivo have not been defined. Therefore, to analyze the impact of KRAS activation in vivo, we generated conditional knock-in mouse models in which the granulosa cells expressed constitutively active KrasG12D. For this Lox-Stop-Lox KrasG12D mice were crossed with mice expressing Cre recombinase driven by either the endogenous Amhr2 promoter (KrasG12D;Amhr2-Cre) or the transgenic Cyp19 (aromatase) promoter (KrasG12D;TgCyp19-Cre). These KrasG12D mutant mice were initially subfertile but became infertile within 4 months of age, thereby exhibiting signs of premature ovarian failure. The mutant ovaries contained numerous, abnormal, follicle-like structures that were devoid of mitotic and apoptotic cells, and failed to express granulosa cell specific marker genes, such as Fshr, Lhcgr, Cyp11a1 and Nr5a2. Of the follicles that proceeded to antral stage, most failed to ovulate and exhibited impaired responses to eCG and hCG as indicated by the reduced expression of ovulation-related genes (Areg, Tnfaip6, Ptgs2, Has2). Phosphorylation of ERK1/2 that is stimulated by LH/hCG in granulosa cells of ovulatory follicles of wild type mice was reduced markedly in the mutant granulosa cells. The reduced phosphorylation of ERK1/2 was due initially to increased expression of the Mkp3, a specific ERK1/2 phosphatase. The functional role of MKP3 was further supported by the ability of Mkp3 siRNA to enhance hormone induced ERK1/2 phosphorylation in cultured granulosa cells. In contrast, elevated levels of phospho-AKT (PKB) were evident in granulosa cells of KrasG12D mutant mouse ovaries even before hormone treatment and were associated with the progressive decline FOXO1 (an AKT target) in the abnormal follicle-like structures in these ovaries. Of note, ovaries of KrasG12D mutant mice did not develop tumors or exhibit signs of granulosa cell transformation. Collectively, these studies show that inappropriate activation of KRAS in granulosa cells of primary follicles blocks the granulosa cell differentiation pathway leading to the persistence of follicles with abnormal, non-mitotic, non-apoptotic, non-differentiated cells. Moreover, those follicles that reach the antral stage, exhibit impaired responses to hormones, leading to ovulation failure. Thus, transient but not sustained activation of RAS in granulosa cells is critical for directing specific events associated with follicular development and the ovulation process whereas inappropriate premature activation leads to premature ovarian failure. Supported in part by NIH-HD-16272 (JSR), HD-07165 (HYF), JSPS No.18688016 (MS)

Either Kras Activation or Pten Loss Similarly Enhance the Dominant-Stable CTNNB1-induced Genetic Program to Promote Granulosa Cell Tumor Development in the Ovary and Testis

Either Kras Activation or Pten Loss Similarly Enhance the Mutant CTNNB1-Induced Genetic Program to Promote Granulosa Cell Tumor Development in Ovary and Testis.

Synergistic Effects of Pten Loss and WNT/CTNNB1 Signaling Pathway Activation in Ovarian Granulosa Cell Tumor Development and Progression.

Cell Type-Specific Targeted Mutations of Kras and Pten Document Proliferation Arrest in Granulosa Cells Versus Oncogenic Insult to Ovarian Surface Epithelial Cells.

Transcriptomic Profiling of Gene Expression Associated with Granulosa Cell Tumor Development in a Mouse Model

Selective Expression Of Kras(G12d) In Granulosa Cells Of The Mouse Ovary Causes Defects In Follicle Development And Ovulation

Lineage tracing of mutant granulosa cells reveals in vivo protective mechanisms that prevent granulosa cell tumorigenesis

Selective Expression of Constitutively Active KrasG12D in Granulosa Cells of the Mouse Ovary Causes Defects in Follicle Development and Ovulation.

Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis

Molecular and Functional Characteristics of Ovarian Surface Epithelial Cells Transformed by Krasg12d and Loss of Pten in A Mouse Model in Vivo

Beta-Catenin (Ctnnb1) Promotes Preovulatory Follicular Development But Represses Lh-Mediated Ovulation And Luteinization

GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling

Pten Deficiency Activates Distinct Downstream Signaling Pathways in A Tissue-Specific Manner

Conditional Deletion of the Pten Gene in the Mouse Prostate Induces Prostatic Intraepithelial Neoplasms at Early Ages but a Slow Progression to Prostate Tumors.

RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line.

Genetic Background Controls Tumor Development In Pten-Deficient Mice

Oncogenic KrasG12D and Smad4/Dpc4 Haploinsufficiency Cooperate to Induce Mucinous Cystic Neoplasms and Invasive Adenocarcinoma of the Pancreas

Loss of Pten Causes Tumor Initiation Following Differentiation of Murine Pluripotent Stem Cells Due to Failed Repression of Nanog.

Jnk and Pten Cooperatively Control the Development of Invasive Adenocarcinoma of the Prostate

Tsc1 Loss Synergizes with Kras Activation in Lung Cancer Development in the Mouse and Confers Rapamycin Sensitivity

Loss of TGF-β Signaling and PTEN Promotes Head and Neck Squamous Cell Carcinoma Through Cellular Senescence Evasion and Cancer-Related Inflammation